rs2022013
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015039.4(NMNAT2):c.85+33465G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.512 in 152,046 control chromosomes in the GnomAD database, including 21,188 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 21188 hom., cov: 32)
Consequence
NMNAT2
NM_015039.4 intron
NM_015039.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.995
Publications
19 publications found
Genes affected
NMNAT2 (HGNC:16789): (nicotinamide nucleotide adenylyltransferase 2) This gene product belongs to the nicotinamide mononucleotide adenylyltransferase (NMNAT) enzyme family, members of which catalyze an essential step in NAD (NADP) biosynthetic pathway. Unlike the other human family member, which is localized to the nucleus, and is ubiquitously expressed; this enzyme is cytoplasmic, and is predominantly expressed in the brain. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.635 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.512 AC: 77856AN: 151928Hom.: 21180 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
77856
AN:
151928
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.512 AC: 77886AN: 152046Hom.: 21188 Cov.: 32 AF XY: 0.514 AC XY: 38208AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
77886
AN:
152046
Hom.:
Cov.:
32
AF XY:
AC XY:
38208
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
13267
AN:
41464
American (AMR)
AF:
AC:
8621
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2201
AN:
3472
East Asian (EAS)
AF:
AC:
3381
AN:
5176
South Asian (SAS)
AF:
AC:
2195
AN:
4816
European-Finnish (FIN)
AF:
AC:
6740
AN:
10572
Middle Eastern (MID)
AF:
AC:
173
AN:
292
European-Non Finnish (NFE)
AF:
AC:
39619
AN:
67962
Other (OTH)
AF:
AC:
1168
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1868
3736
5605
7473
9341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1894
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.